Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,527 | 40 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $663.93 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $445.29 | 4 | $0 (2023) |
| Inari Medical, Inc. | $344.93 | 2 | $0 (2024) |
| Grifols USA, LLC | $293.49 | 3 | $0 (2024) |
| AbbVie Inc. | $247.40 | 4 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $234.70 | 3 | $0 (2024) |
| PFIZER INC. | $229.88 | 3 | $0 (2023) |
| CSL Behring | $160.18 | 2 | $0 (2024) |
| Genentech USA, Inc. | $125.00 | 1 | $0 (2019) |
| Mallinckrodt LLC | $125.00 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $867.23 | 8 | Janssen Pharmaceuticals, Inc ($164.20) |
| 2023 | $676.24 | 7 | AstraZeneca Pharmaceuticals LP ($137.68) |
| 2022 | $531.30 | 6 | Inari Medical, Inc. ($191.45) |
| 2021 | $468.19 | 8 | AstraZeneca Pharmaceuticals LP ($183.64) |
| 2020 | $118.69 | 2 | Allergan, Inc. ($100.00) |
| 2019 | $379.29 | 4 | Genentech USA, Inc. ($125.00) |
| 2018 | $395.62 | 4 | E.R. Squibb & Sons, L.L.C. ($125.00) |
| 2017 | $90.29 | 1 | PFIZER INC. ($90.29) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $118.61 | General |
| Category: IMMUNOLOGY | ||||||
| 08/13/2024 | Grifols USA, LLC | HyperRAB (Biological) | Food and Beverage | In-kind items and services | $102.37 | General |
| Category: Immunology | ||||||
| 07/16/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $119.95 | General |
| Category: Inflammation | ||||||
| 06/18/2024 | Inari Medical, Inc. | CT THROMBECTOMY SYSTEM KIT (Device), FLOWTRIEVER CATHETER, S | Food and Beverage | In-kind items and services | $153.48 | General |
| Category: VTE | ||||||
| 06/11/2024 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $117.68 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 04/11/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/12/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $145.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/13/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $90.94 | General |
| Category: Cardiovascular | ||||||
| 11/14/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $137.68 | General |
| Category: Rare Disease | ||||||
| 10/12/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, ZAVZPRET | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/12/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $117.93 | General |
| Category: COVID-19 | ||||||
| 05/09/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $123.53 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/11/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $111.62 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/07/2023 | Grifols USA, LLC | HyperRAB (Biological) | Food and Beverage | In-kind items and services | $124.21 | General |
| Category: Immunology | ||||||
| 02/09/2023 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $42.50 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 09/08/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $123.97 | General |
| Category: Rare Disease | ||||||
| 05/18/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $18.76 | General |
| 05/12/2022 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $191.45 | General |
| Category: VTE | ||||||
| 04/14/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $118.59 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/10/2022 | Grifols USA, LLC | HyperRAB (Biological) | Food and Beverage | In-kind items and services | $66.91 | General |
| Category: Immunology | ||||||
| 03/01/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/16/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/15/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $123.97 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/11/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $103.10 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/09/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $92.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 194 | 197 | $269,470 | $21,362 |
| 2022 | 5 | 263 | 266 | $330,519 | $28,644 |
| 2021 | 5 | 275 | 278 | $326,976 | $28,022 |
| 2020 | 4 | 350 | 359 | $340,810 | $30,051 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 88 | 91 | $165,323 | $13,153 | 8.0% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 56 | 56 | $65,572 | $5,435 | 8.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 16 | 16 | $35,632 | $2,557 | 7.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 34 | 34 | $2,943 | $217.60 | 7.4% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 124 | 126 | $221,712 | $18,835 | 8.5% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 54 | 54 | $62,320 | $5,615 | 9.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 15 | 15 | $33,405 | $2,829 | 8.5% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 16 | 16 | $8,402 | $999.40 | 11.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 54 | 55 | $4,680 | $364.57 | 7.8% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 129 | 130 | $225,296 | $18,997 | 8.4% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 40 | 40 | $46,847 | $4,080 | 8.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 18 | 18 | $40,086 | $3,457 | 8.6% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 17 | 17 | $8,413 | $1,016 | 12.1% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 71 | 73 | $6,334 | $471.96 | 7.5% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 156 | 158 | $262,095 | $23,123 | 8.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 17 | 17 | $36,481 | $3,204 | 8.8% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 26 | 26 | $29,072 | $2,630 | 9.0% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 151 | 158 | $13,162 | $1,093 | 8.3% |
About Dr. Jesse Caron, MD
Dr. Jesse Caron, MD is a Emergency Medical Services healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1346368024.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jesse Caron, MD has received a total of $3,527 in payments from pharmaceutical and medical device companies, with $867.23 received in 2024. These payments were reported across 40 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($3,527).
As a Medicare-enrolled provider, Caron has provided services to 1,082 Medicare beneficiaries, totaling 1,100 services with total Medicare billing of $108,078. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Emergency Medical Services
- Location Orlando, FL
- Active Since 03/27/2007
- Last Updated 07/08/2007
- Taxonomy Code 207PE0004X
- Entity Type Individual
- NPI Number 1346368024
Products in Payments
- XARELTO (Drug) $663.93
- ELIQUIS (Drug) $445.82
- DALVANCE (Drug) $347.40
- ANDEXXA (Biological) $346.22
- HyperRAB (Biological) $293.49
- FLOWTRIEVER CATHETER, S (Device) $191.45
- LOKELMA (Drug) $183.64
- Kcentra (Biological) $160.18
- CT THROMBECTOMY SYSTEM KIT (Device) $153.48
- OFIRMEV (Drug) $125.00
- TAVNEOS (Drug) $119.95
- NUCALA (Biological) $118.61
- Veklury (Drug) $117.93
- Precision Flow (Device) $115.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medical Services Doctors in Orlando
Alkesh Brahmbhatt, Do, DO
Emergency Medical Services — Payments: $100,522
Regan Schwartz, Md, MD
Emergency Medical Services — Payments: $6,030
Herbert Cooper, Md, MD
Emergency Medical Services — Payments: $4,082
Miguel Acevedo, Md, MD
Emergency Medical Services — Payments: $2,980
Ernest Page, Md, MD
Emergency Medical Services — Payments: $2,763
David Goldman, Do, DO
Emergency Medical Services — Payments: $2,632